This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sakr WA et al. (1996) Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol 30: 138–144
Jemal A et al. (2003) Cancer Statistics, 2003. CA Cancer J Clin 53: 5–26
Thompson IM et al. (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349: 215–224
Harlan SR et al. (2003) Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. J Urol 170: 1804–1807
Brandeis J et al. (2000) A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Cancer 89: 1792–1799
Lee WR et al. (2003) The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States. Cancer 98: 1987–1994
Wilt TJ et al. (1999) An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes. Med Care 37: 1046–1056
Acknowledgements
The synopsis was written by Suzanne Farley, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Thrasher, J. Should men with serum PSA levels of 4.0 ng/ml or less undergo a prostate biopsy?. Nat Rev Urol 1, 12–13 (2004). https://doi.org/10.1038/ncpuro0013
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0013